A two-antibody cocktail that targets Nipah and Hendra’s receptor-binding and fusion proteins protects animals from lethal ...
Bispecific antibodies have emerged as a transformative class of therapies in multiple myeloma and beyond, but the need for ...
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress ...
5don MSN
Scientists develop antibody against the virus hiding in 95% of adults and linked to cancer and MS
Targeting the virus at entry To breach the immune system, EBV depends on two surface proteins: gp350 and gp42. It uses these ...
Dual long‑acting antibodies that lock RSV’s fusion protein from two sides protect against RSV A and B and prevent resistance, ...
In some parts of the US, up to 30 percent of people may carry the antibody behind a red meat allergy spurred by tick bites, ...
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...
Pfizer announced that a late-stage trial in lung cancer for a Seagen-derived ADC, sigvotatug vedotin, has failed. Phase I ...
One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...
Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading conferences dedicated to therapeutic antibodies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results